SOPHARMA AD - Received corrected tender offer addressed to the shareholders of "Sopharma" AD from "Donev Investments Holding" AD

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 5 / 2023

Date of issue: 2023-01-13

Short name of the issuer

SOPHARMA AD

Subject

Received corrected tender offer addressed to the shareholders of "Sopharma" AD from "Donev Investments Holding" AD

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria, January 13, 2023 – According to the requirements of art. 100t of LPOS, the Board of Directors of "Sopharma" AD (SFA: "BFB - Sofia", SPH: Warsaw Stock Exchange) announces that on January 13, 2023, "Sopharma" AD received a corrected tender offer, registered with the Financial Supervision Commission from "DONEV INVESTMENTS HOLDING" AD - a shareholder directly owning 37,600,000 ordinary, non-available shares with voting rights, representing 27.89% of the capital and votes in the GMS of "SOPHARMA" AD, on the basis of art. 149b of the Law on the Public Offering of Securities for the purchase of shares from the remaining shareholders of "SOPHARMA" AD.

Annexes

File Description

Sales_Revenues_for_December_2022_espi.pdf Received corrected tender offer addressed to the shareholders of "Sopharma" AD from "Donev Investments Holding" AD

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2023-01-13 Ognian Donev Executive director